Patent US4863907A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4863907A Expired / Lapsed US ⏱️ 0.0 years remaining

Crosslinked glycosaminoglycans and their use

Assignee: Seikagaku Corp
•
Filing: 1985-06-25
•
Granted: 1989-09-05
•
Expires: 2005-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Crosslinked glycosaminoglycans or salts thereof prepared by crosslinking glycosaminoglycan or salts thereof with a polyfunctional epoxy compound wherein a crosslinking index is 0.005 or more per 1 mole of repeating disaccharides in glycosaminoglycan, and having various medical and cosmetic uses.

Inventors

  • 👤 Katukiyo Sakurai
  • 👤 Yoshio Ueno
  • 👤 Takashi Okuyama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 04:14
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; A; A61; A61K; A61K8/00; A61K8/18; A61K8/72; A61K8/73; A61K8/735; A61K9/00; A61K9/70; A61L; A61L31/00; A61L31/04; A61L31/042; A61L31/043; A61L31/044; A61Q; A61Q19/00; C08B37/0072; C08L; C08L5/00; C08L5/08

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 67 words
A crosslinked glycosaminoglycan or a salt thereof obtainable by crosslinking a glycosaminoglycan (provided that hyaluronic acid is excluded) or a salt thereof with a polyfunctional epoxy compound wherein a crosslinking index is 0.005 or more per 1 mole of repeating disaccharides in said glycosaminoglucan and wherein said glycosaminoglycan is chondroitin sulfate, heparin, heparan sulfate, keratan sulfate or keratanpolysulfate and said polyfunctional epoxy compound is epichlorohydrin or epibromohydrin.
Claim 2
Dependent Claim 67 words
A crosslinked glycosaminoglycan or a salt thereof obtainable by crosslinking a glycosaminoglycan (provided that hyaluronic acid is excluded) or a salt thereof with a polyfunctional epoxy compound wherein a crosslinking index is 0.005 or more per 1 mole of repeating disaccharides in said glycosaminoglucan and wherein said glycosaminoglycan is chondroitin sulfate, heparin, heparan sulfate, keratan sulfate or keratanpolysulfate and said polyfunctional epoxy compound is epichlorohydrin or epibromohydrin.
Claim 3
Dependent Claim 34 words
The crosslinked glycosaminoglycan or a salt thereof as claimed in claim 1 wherein it has a crosslinking index of 0.165 or more per 1 mole of repeating disaccharides in said glycosaminoglycan and is water-insoluble.
Claim 4
Dependent Claim 57 words
A pharmaceutical composition for applying to vitreous body comprising an active ingredient in combination with an ophthamologically acceptable carrier or diluent, wherein said active ingredient is a crosslinked glycosaminoglycan or a salt thereof as claimed in claim 1 and is present in such an amount that the viscosity of the composition is not more than 50,000 cp.
Claim 5
Dependent Claim 13 words
The composition of claim 3 wherein the viscosity is at least 5,000 cp.
Claim 6
Dependent Claim 13 words
The composition of claim 3 wherein the viscosity is 5,000 to 30,000 cp.
Claim 7
Dependent Claim 31 words
A pharmaceutical composition for applying to a wound for healing, comprising a wound healing effective amount of the crosslinked glycosaminoglycan or salt thereof, of claim 1, in a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim 22 words
The pharmaceutical composition of claim 6 comprising a 2% solution of the crosslinked glycosaminoglycan or salt thereof in a physiological saline solution.

References Cited (Backward Citations)

US3507851A Cited
US3829412A Cited
US4098859A Cited
US4470975A Cited
JPS57185208A Cited
JPS6084225A Cited
US4532267A Cited
US4582865A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-09-04 1993-03-06 1993-09-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-09-04 1997-03-06 1997-09-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-09-04 2001-03-06 2001-09-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag